Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy of the Timing of the Administration of a Telmisartan/S-Amlodipine
(Telminuvo®Tab. 40/2.5mg) on 24-hour BP Control in Hypertensive Patients Inadequately
Controlled by Telmisartan Monotherapy